Therapeutic potential of convalescent plasma and hyperimmune immunoglobulins against SARS-CoV-2 BQ.1, BQ.1.1, and XBB variants


Lorenza Bellusci, Hana Golding, and Surender Khurana Journal of Clinical Investigation Published 2023 - More infoView PDF  Convalescent plasma (CP) and hyperimmune intravenous immunoglobulins (IVIGs) are routinely used to treat patients with COVID-19.…[...]

Bivalent Covid-19 Vaccines — A Cautionary Tale.


List of authors. Paul A. Offit, M.D New England Journal of Medicine January 23, 2023 in Wuhan, China. Two months later, the original strain of SARS-CoV-2, called the Wuhan-1 or…[...]

What COVID-19 variants are going around in November 2022?


Authors: Nebraska Medicine November 1, 2022 There are currently more than 37,000 cases reported in the United States per day, with test positivity of 8.6%. When test positivity is above 5%,…[...]

Omicron’s Mutations Impaired Vaccine Effectiveness, CDC Says


Authors: Madison Muller  August 25, 2022 Bloomberg Almost 40% of people hospitalized in the US with the Covid subvariant that circulated this spring were vaccinated and boosted, highlighting how new…[...]